DAVOS, Switzerland—The key to building resilient health care systems around the world is rebuilding trust in health care. That was one of the fundamental points made in a fascinating panel discussion I moderated this morning on the first official day of programming here at the 50th annual meeting of the World Economic Forum.
KINGSTON, Jamaica — Sydonna Tugwell, a laboratory technologist at the Medicines Quality Control and Surveillance Department of the Caribbean Public Health Agency, or CARPHA, arrives for work each day at an inconspicuous building in Kingston’s Hope Gardens. Outside, the botanical surroundings are filled with birdsong and the city’s traffic is down to a dull hum. Perhaps surprisingly, it is in this tranquil setting that Tugwell and seven other colleagues are playing a crucial role in transforming the region’s health care system.
In July, a mail carrier in Phoenix, Arizona, claimed to have cooked a steak to an internal temperature of 142 degrees Fahrenheit—medium rare—on the dashboard of his delivery vehicle, which doesn't have air conditioning.
Universal health coverage depends on affordable medicines. But pushing down prices without also investing in quality assurance will increase the sale of substandard and falsified drugs, warns Elizabeth Pisani.
Science can and does change humanity. Yet while we live in an age of extraordinary advances, profound health challenges remain. Global health emergencies such as rapidly rising drug-resistance, epidemic threats from diseases known and unknown, mental health, and the escalating climate crisis are a threat to us all.
A fridge designed for vaccines and medicines has “harnessed the power of nature” to keep its contents cold, even with intermittent access to electricity.
Substandard and falsified medications pose significant risks to global health. Nearly one in five antimalarials circulating in low- and middle-income countries are substandard or falsified. We assessed the health and economic impact of substandard and falsified antimalarials on children under five in Nigeria, where malaria is endemic and poor-quality medications are commonplace.
To tackle one of the most urgent public health crises facing the world today – antimicrobial resistance (AMR) – universal health coverage (UHC) must be realized. It’s time to take action by ensuring that everyone has access to safe, effective, quality-assured medicines.
When a poor country becomes wealthier, it's a good thing, right? Not if the country is trying to buy essential medicines.